NOVARTIS AG NAMENS-AKTIEN SF 0,5/ CH0012005267 /
| 2024-11-16 1:04:01 PM | Chg. 0.000 | Volume | Bid1:04:01 PM | Ask1:04:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 97.600EUR | 0.00% | - Turnover: - |
97.600Bid Size: - | 98.050Ask Size: - | 223.63 bill.EUR | - | - |
Assets
|
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 IFRS in mill. USD |
2022 IFRS in mill. USD |
2023 IFRS in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 12,069 | 12,263 | 11,545 | 10,764 | 10,924 | ||||||
| Intangible Assets | 30,464 | 36,809 | 34,182 | 31,644 | 26,879 | ||||||
| Long-Term Investments | 2,518 | 2,901 | 3,036 | 2,411 | 2,812 | ||||||
| Fixed Assets | 88,866 | 102,386 | 86,077 | 80,543 | 69,464 | ||||||
| Inventories | 5,982 | 7,131 | 6,666 | 7,175 | 5,913 | ||||||
| Accounts Receivable | 8,301 | 8,217 | 8,005 | 8,066 | 7,107 | ||||||
| Cash and Cash Equivalents | 11,112 | 9,658 | 12,407 | 7,517 | 13,393 | ||||||
| Current Assets | 28,663 | 29,673 | 45,718 | 36,910 | 30,481 | ||||||
| Total Assets | 118,370 | 132,059 | 131,795 | 117,453 | 99,945 | ||||||
Liabilities
|
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 IFRS in mill. USD |
2022 IFRS in mill. USD |
2023 IFRS in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5,424 | 5,403 | 5,553 | 5,146 | 4,926 | ||||||
| Long-term debt | 20,353 | 26,259 | 22,902 | 20,244 | 18,436 | ||||||
| Liabilities to Banks | 27,384 | 36,044 | 29,197 | - | - | ||||||
| Provisions | 8,061 | 9,880 | 5,485 | 4,906 | 17,986 | ||||||
| Liabilities | 62,819 | 75,393 | 63,973 | 58,030 | 53,195 | ||||||
| Share Capital | 936 | 913 | 901 | - | 825 | ||||||
| Total Equity | 55,474 | 56,598 | 67,655 | 59,423 | 46,667 | ||||||
| Minority Interests | 77 | 68 | 167 | - | 83 | ||||||
| Total liabilities equity | 118,370 | 132,059 | 131,795 | 117,453 | 99,945 | ||||||
Income Statement
|
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 IFRS in mill. USD |
2022 IFRS in mill. USD |
2023 IFRS in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 47,498 | 48,659 | 51,626 | 50,545 | 46,660 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 9,086 | 10,152 | 11,689 | 9,197 | 9,769 | ||||||
| Interest Income | -850 | -869 | -811 | - | -633 | ||||||
| Income Before Taxes | 8,940 | 9,878 | 26,137 | - | 9,123 | ||||||
| Income Taxes | 1,793 | 1,807 | 2,119 | 1,416 | 551 | ||||||
| Minority Interests Profit | 0.0000 | 1 | 3 | 9 | 4 | ||||||
| Net Income | 11,737 | 8,072 | 24,018 | 6,955 | 14,850 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 IFRS in mill. USD |
2022 IFRS in mill. USD |
2023 IFRS in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 13,625 | 13,650 | 15,071 | 4,111 | 14,458 | ||||||
| Cash Flow from Investing Activities | -2,226 | -13,182 | 4,208 | -1,467 | 5,596 | ||||||
| Cash Flow from Financing | -13,627 | -2,208 | -16,264 | -3,994 | -17,564 | ||||||
| Decrease / Increase in Cash | -2,159 | -1,454 | 2,749 | - | - | ||||||
| Employees | 103,914 | 105,794 | 104,323 | - | 76,057 | ||||||
